Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Invest New Drugs. 2018 Aug 3;37(2):364–374. doi: 10.1007/s10637-018-0647-0

Fig. 1.

Fig. 1

Structure of Apra S10 (a) and the effects of Apra S10 on cell growth of EC68, EC46 (primary pancreatic cancer cells) and PANC-1 (exocrine pancreatic cancer cells) using an MTT assay at 48 hours (b).